FDA-Approved Cannabinoid Medications VA Can Prescribe

Three FDA-approved cannabinoid medications occupy a different legal category than "medical marijuana." Because they have been approved by the FDA for specific indications, VA providers can prescribe them through normal VA pharmacy channels. Here is what they are, what they are approved for, and when they might be options for veterans.

Why These Are Different

Epidiolex, dronabinol (Marinol), and nabilone (Cesamet) are FDA-approved medications — not Schedule I. VA providers can prescribe them through normal VA pharmacy channels, VA covers them as part of standard benefits, and they are governed by ordinary prescription rules, not medical cannabis program rules.

Small prescription pill bottle beside a tincture dropper bottle on a kitchen table

Epidiolex (Cannabidiol Oral Solution)

Active ingredient: 100 mg/mL cannabidiol (CBD) in a sesame oil-based oral solution
FDA approval: June 25, 2018 (the first FDA-approved plant-derived cannabis medication)
Schedule: Originally Schedule V; completely descheduled by the DEA on April 6, 2020
Approved indications: Seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients 1 year and older
Who might benefit: Veterans (or their dependents) with treatment-resistant seizure disorders in one of the approved conditions
Not approved for: PTSD, anxiety, chronic pain, sleep, or general wellness — none of these have FDA approval

Dronabinol (Marinol / Syndros — Synthetic THC)

Active ingredient: Synthetic delta-9-tetrahydrocannabinol (THC)
FDA approval: May 31, 1985 (capsule form, Marinol); 2016 (oral solution form, Syndros)
Schedule: Originally Schedule II; rescheduled to Schedule III in 1999
Approved indications: Chemotherapy-induced nausea and vomiting in patients who have failed conventional antiemetic treatments; anorexia associated with AIDS-related weight loss
Off-label use: Some providers use dronabinol off-label for chronic pain, appetite stimulation in other conditions, and sleep — though evidence is limited
Practical considerations: Oral dronabinol has slow onset (1–2 hours) and variable bioavailability. It produces the full range of THC effects, including psychoactivity. It is not "CBD" — it is pure THC, and veterans considering it should understand that.

Nabilone (Cesamet — Synthetic Cannabinoid Analog)

Active ingredient: Nabilone (a synthetic analog of THC)
FDA approval: 1985
Schedule: Schedule II controlled substance
Approved indications: Chemotherapy-induced nausea and vomiting in patients who have failed conventional antiemetic treatments
Off-label use for PTSD-associated nightmares: The American Academy of Sleep Medicine (2018) listed nabilone among therapies that "may be used" for PTSD-associated nightmares. The Jetly et al. 2015 trial (PMID 25467221) in 10 Canadian military personnel showed nabilone significantly reduced CAPS nightmare scores vs. placebo. The Fraser 2009 open-label trial in 47 Canadian Forces patients with treatment-resistant nightmares found 72% experienced cessation or significant reduction.
Evidence quality for PTSD nightmares:
Low Evidence — very small samples, limited blinding, Canadian military populations only

Jetly R, Heber A, Fraser G, Boisvert D "The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares" Psychoneuroendocrinology 2015. PMID: 25467221

What These Medications Cannot Do

None of the three FDA-approved cannabinoid medications is a replacement for the plant cannabis products available in state dispensaries. They have different pharmacokinetics, different cannabinoid profiles, different delivery routes, and different cost structures. Dronabinol in particular produces the full range of THC effects; it is not "safer" than plant cannabis by virtue of being synthetic. Veterans choosing between FDA-approved options and dispensary products should understand that the decision is less about "legal vs. illegal" and more about which delivery system, which cannabinoid profile, and which evidence base matches their specific needs.

When VA Might Prescribe These

Epidiolex: For veterans or dependents with Lennox-Gastaut, Dravet, or tuberous sclerosis complex seizures
Dronabinol: For veterans undergoing chemotherapy with refractory nausea, or AIDS-related anorexia. Off-label use for other conditions is at VA provider discretion.
Nabilone: For veterans undergoing chemotherapy with refractory nausea. Off-label use for PTSD nightmares is at VA provider discretion and is not a standard first-line recommendation — the evidence base remains limited and small.

None of these medications is indicated for PTSD as a primary diagnosis. Nabilone's off-label use for trauma-associated nightmares is the closest approximation, but veterans interested in this pathway should discuss it with a VA mental health provider who can weigh the small evidence base against their specific clinical situation.